An Appraisal of Clinicopathologic Parameters Associated with Response to Neoadjuvant Treatment in HER2 Positive Breast Cancer

被引：0
|
作者：
Rong, Juan [1 ]
Hasteh, Farnaz [1 ]
Fadare, Oluwole [1 ]
Zare, Somaye [1 ]
机构：
[1] Univ Calif San Diego, La Jolla, CA 92093 USA
来源：
MODERN PATHOLOGY | 2020年 / 33卷 / SUPPL 2期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
251
引用
收藏
页码：248 / 248
页数：1
相关论文
共 50 条
  • [1] An Appraisal of Clinicopathologic Parameters Associated with Response to Neoadjuvant Treatment in HER2 Positive Breast Cancer
    Rong, Juan
    Hasteh, Farnaz
    Fadare, Oluwole
    Zare, Somaye
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 248 - 248
  • [2] Imaging and Clinicopathologic Features Associated With Pathologic Complete Response in HER2-positive Breast Cancer Receiving Neoadjuvant Chemotherapy With Dual HER2 Blockade
    Yoon, Ga Young
    Chae, Eun Young
    Cha, Joo Hee
    Shin, Hee Jung
    Choi, Woo Jung
    Kim, Hak Hee
    Kim, Jeong Eun
    Kim, Sung-Bae
    CLINICAL BREAST CANCER, 2020, 20 (01) : 25 - 32
  • [3] The association of higher tumor HER2 load with treatment response to neoadjuvant therapy in HER2 positive breast cancer patients
    Lillemoe, T. J.
    Susnik, B.
    Grimm, E.
    Kang, S-H L.
    Swenson, K. K.
    Krueger, J. L.
    Finkelstein, M. J.
    Tsai, M. L.
    CANCER RESEARCH, 2017, 77
  • [4] Predictive Biomarker of Response to Neoadjuvant Therapy in HER2 Positive Breast Cancer
    Zhao, Jing
    Meisel, Jane
    Suo, Aili
    Zhang, Chao
    Wei, Zhimin
    Aneja, Ritu
    Li, Zaibo
    Nahta, Rita
    Li, Xiaoxian
    LABORATORY INVESTIGATION, 2019, 99
  • [5] Prediction of response to neoadjuvant chemotherapy in HER2 positive breast cancer by MammaTyper®
    Scatena, C.
    Belcastro, E.
    Scarpitta, R.
    Naccarato, A. G.
    EUROPEAN JOURNAL OF CANCER, 2024, 200 : 30 - 30
  • [6] Percentage of HER2 immunohistochemistry complete membrane staining is not significantly associated with response to neoadjuvant therapy in HER2 positive breast cancer
    Li, Xiaoxian
    Zhao, Jing
    Zhang, Chao
    Li, Zaibo
    LABORATORY INVESTIGATION, 2019, 99
  • [7] Percentage of HER2 immunohistochemistry complete membrane staining is not significantly associated with response to neoadjuvant therapy in HER2 positive breast cancer
    Li, Xiaoxian
    Zhao, Jing
    Zhang, Chao
    Li, Zaibo
    MODERN PATHOLOGY, 2019, 32
  • [8] HER2 Immunohistochemistry Positivity is Strongly Predictive of HER2 Positive Breast Cancer Response to Neoadjuvant Therapy
    Zhao, Jing
    Zhang, Chao
    Suo, Aili
    Shi, Qiuying
    Wei, Zhimin
    Li, Zaibo
    Krishnamurti, Uma
    Li, Xiaoxian
    MODERN PATHOLOGY, 2019, 32
  • [9] HER2 Immunohistochemistry Positivity is Strongly Predictive of HER2 Positive Breast Cancer Response to Neoadjuvant Therapy
    Zhao, Jing
    Meisel, Jane
    Suo, Aili
    Zhang, Chao
    Wei, Zhimin
    Aneja, Ritu
    Li, Zaibo
    Nahta, Rita
    Li, Xiaoxian
    MODERN PATHOLOGY, 2019, 32
  • [10] HER2 Immunohistochemistry Positivity is Strongly Predictive of HER2 Positive Breast Cancer Response to Neoadjuvant Therapy
    Zhao, Jing
    Zhang, Chao
    Suo, Aili
    Shi, Qiuying
    Wei, Zhimin
    Li, Zaibo
    Krishnamurti, Uma
    Li, Xiaoxian
    LABORATORY INVESTIGATION, 2019, 99
12345